David Hull

Journal of Optimization Theory and Applications -     

Secondary Metabolites of Litchi chinensis

Chemistry of Natural Compounds -     

The Interference of Magnetoelastic Waves in an Yttrium Iron Garnet Film

Physics of the Solid State - The interference of excited and received by current antennae magnetoelastic waves counterpropagating in an yttrium iron garnet film is experimentally studied. It is...     

Preparation and Properties of Sr3B2O6:Dy3+, Eu3+ White Phosphors Using the High-Temperature Solid-State Method

Journal of Applied Spectroscopy - Sr3B2O6:Dy3+, Eu3+ single-matrix white-light-emitting materials are prepared using the high-temperature solid-state method. The microstructure, emission spectrum,...     

On the Local Stress Fields in Inhomogeneous Media Determined by the Acoustic Emission Method

Physics of the Solid State - Local internal stresses in two natural inhomogeneous materials differing in the structure have been calculated using analysis of pauses between acoustic emission...     

Comparative Study of LiInSe2 Single Crystals for Thermal-Neutron Detection

Crystallography Reports - Two LiInSe2 single crystals, grown under different conditions, have been studied. Characteristics of these crystals for neutron detection have been compared using...     

A study for the selection of NPE-free cocktails for LSC routine measurements

Journal of Radioanalytical and Nuclear Chemistry - In this paper a study for the selection of an NPE (nonylphenol ethoxylates)—free cocktail is discussed in order to be used for our routine...     

Anti-fibrosis attributes: UHPLC-MS/MS-based pharmacokinetics profiling of a novel autotaxin inhibitor with excellent in vivo efficacy in rat

3,4-Difluorobenzyl(1-ethyl-5-(4-((4-hydroxypiperidin-1-yl)-methyl)thiazol-2-yl)-1H-indol-3-yl)carbamate (NAI59), a small molecule with outstanding therapeutic effectiveness to anti-pulmonary fibrosis, was developed as an autotaxin inhibitor candidate compound. To evaluate the pharmacokinetics and plasma protein binding of NAI59, a UPLC–MS/MS method was developed to quantify NAI59 in plasma and phosphate-buffered saline. The calibration curve linearity ranged from 9.95 to 1990.00 ng/mL in plasma. The accuracy was −6.8 to 5.9%, and the intra- and inter-day precision was within 15%. The matrix effect and recovery, as well as dilution integrity, were within the criteria. The chromatographic and mass spectrometric conditions were also feasible to determine phosphate-buffered saline samples, and it has been proved that this method exhibits good precision and accuracy in the range of 9.95–497.50 ng/mL in phosphate-buffered saline. This study is the first to determine the pharmacokinetics, absolute bioavailability, and plasma protein binding of NAI59 in rats using this established method. Therefore, the pharmacokinetic profiles of NAI59 showed a dose-dependent relationship after oral administration, and the absolute bioavailability in rats was 6.3%. In addition, the results of protein binding showed that the combining capacity of NAI59 with plasma protein attained 90% and increased with the increase in drug concentration.     

Some Problems of Nonlinear Dynamics of Turbulent Thermals

Radiophysics and Quantum Electronics - A well-known simplified model of turbulent convection from local sources of buoyancy and/or momentum acting for a short time has been developed and...     

Operator Interpolation and Systems of Linear Equations and Inequalities in Euclidean Spaces

Ukrainian Mathematical Journal - We establish new criteria of compatibility for a linear system of equations (equivalent to the Kronecker–Capelli theorem) or inequalities (equivalent to the...